|
Zyban, an anti-smoking
drug, may have been one of the factors contributing to the
suicide death of an 18-year-old college student.
The teenager was prescribed
Zyban, which is manufactured by pharmaceutical company GlaxoSmithKline,
to help him quit smoking. After taking the drug, he told family
members that he felt "an immediate change within himself."
Reportedly, the teenager changed from being "outgoing and
happy" to suffering from bouts of depression.
He stopped taking
the drug after one week, however six months later was found
to have committed suicide.
According to a
psychiatrist who treated the boy, he had a mixed anxiety depressive
disorder that may have been affected by Zyban. The coroner
also stated that the effects of Zyban may have contributed
to the student’s suicide, however mentioned that the
boy’s obsessive personality and heavy drinking may have
also played a role.
Another physician
and expert of drug effects stated that Zyban could not have
been in the student’s system when he died, however it
could have contributed to his altered state of mind.
A spokeswoman for
GlaxoSmithKline said the drug has been tested for safety and
has been used by about 10.5 million people worldwide. She
mentioned that mood changes, including depression and anxiety,
often occur when people try to stop smoking, regardless of
whether a drug is used or not.
BBC
News February 24, 2003
|